Clinical Trial: A First-In-Human Study of ARO-033 in Adult Participants

U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07662096) titled 'A First-In-Human Study of ARO-033 in Adult Participants' on June 18.

Brief Summary: This study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of single and multiple doses of ARO-033 compared to placebo in adult normal healthy volunteers (NHVs).

Study Start Date: June 22

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: ARO-033

ARO-033 will be administered as a subcutaneous (SC) injection per schedule specified in the arm description.

DRUG: Placebo

Placebo matching to ARO-033 will be administered as SC injection per schedule specified in the arm...